Correlation Between Nordinvestments and Pharma Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nordinvestments and Pharma Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nordinvestments and Pharma Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nordinvestments AS and Pharma Equity Group, you can compare the effects of market volatilities on Nordinvestments and Pharma Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nordinvestments with a short position of Pharma Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nordinvestments and Pharma Equity.

Diversification Opportunities for Nordinvestments and Pharma Equity

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Nordinvestments and Pharma is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Nordinvestments AS and Pharma Equity Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharma Equity Group and Nordinvestments is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nordinvestments AS are associated (or correlated) with Pharma Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharma Equity Group has no effect on the direction of Nordinvestments i.e., Nordinvestments and Pharma Equity go up and down completely randomly.

Pair Corralation between Nordinvestments and Pharma Equity

If you would invest  123.00  in Nordinvestments AS on September 1, 2024 and sell it today you would earn a total of  0.00  from holding Nordinvestments AS or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Nordinvestments AS  vs.  Pharma Equity Group

 Performance 
       Timeline  
Nordinvestments AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nordinvestments AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Nordinvestments is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Pharma Equity Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pharma Equity Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Nordinvestments and Pharma Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nordinvestments and Pharma Equity

The main advantage of trading using opposite Nordinvestments and Pharma Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nordinvestments position performs unexpectedly, Pharma Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma Equity will offset losses from the drop in Pharma Equity's long position.
The idea behind Nordinvestments AS and Pharma Equity Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years